Eric Stecker, MD, chair of the American College of Cardiology's Science and Quality Committee, joined us for an exclusive interview. 

The new analysis, published in the New England Journal of Medicine, represents the latest chapter in one of interventional cardiology’s largest ongoing debates.

Three months of anticoagulation therapy is the go-to option when treating these younger patients—but it could be time for a change.

The study compared two different doses of vitamin D with a placebo. 

The study included more than 400 patients with a history of mild or moderate COVID-19. 

All patients included in the analysis faced a high risk of complications, researchers noted. 

All patients originally presented with a dysfunctional RVOT conduit or stented bioprosthetic pulmonary valve.

This trend was even seen in areas where COVID-19 rates were relatively low, researchers found.

About 80% said they were happy prior to the pandemic, with about 6 in 10 now feeling that same way outside of work, according to new survey data.